Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2020 Filed Aug 14, 2020 20:32 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 4,185 | $99.69 | $417,198.88 |
DisclosureSEC source: 0001209191-20-046797 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,510 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $99.38 - $99.96. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 42,531 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 17:00 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 1,916 | $100.80 | $193,140.85 |
DisclosureSEC source: 0001209191-20-046391 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,271 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $100.08 - $100.955. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,772 shares of common stock and 8,499 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 21:10 UTC |
Martin Lynn CPresident, ICE Data Services
|
SaleCommon Stock | 2,500 | $100.04 | $250,111.00 |
DisclosureSEC source: 0001209191-20-045976 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, ICE Data Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,018 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $100.00 - $100.16. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: Amount of securities beneficially owned includes 136 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2020. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,819 shares of common stock and 11,199 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 21:10 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 1,000 | $100.00 | $100,000.00 |
DisclosureSEC source: 0001209191-20-045975 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,952 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 136 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2020. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 58,001 shares of common stock and 1,419 unvested restricted stock units ("RSUs"), and 20,532 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 26,375 | $0.00 Strike: $22.43 | $0.00 |
DisclosureSEC source: 0001209191-20-046160 · doc4.xml · derivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,375 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 26,375 | $100.17 | $2,642,002.21 |
DisclosureSEC source: 0001209191-20-046160 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,431 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $100.00 - $100.46. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: Amount of securities beneficially owned includes 136 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2020. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 111,418 shares of common stock and 25,013 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 26,375 | $22.43 | $591,591.25 |
DisclosureSEC source: 0001209191-20-046160 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| July 29, 2020 Filed Jan 29, 2021 16:33 UTC |
SALERNO FREDERIC VDirector
|
GiftCommon Stock | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006110 · doc5.xml · nonDerivative · entry 1 SALERNO FREDERIC V · CIK 0001180138 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,107 F1 · shares: The transaction involved a gift of 1,069 shares of the Issuer's common stock by the reporting person to a family trust. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 16:52 UTC |
Forneri Jean MarcDirector
|
SaleCommon Stock | 3,000 | $96.01 | $288,027.00 |
DisclosureSEC source: 0001209191-20-043613 · doc4.xml · nonDerivative · entry 1 Forneri Jean Marc · CIK 0001343872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,811 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $96.00 - $96.01. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 16,832 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 63,468 | $95.88 | $6,085,311.84 |
DisclosureSEC source: 0001209191-20-043614 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,271,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $95.53 - $96.17. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 16:53 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 36,532 | $94.94 | $3,468,512.47 |
DisclosureSEC source: 0001209191-20-043614 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,335,173 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $94.53 - $95.52. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 16:35 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,448 | $92.68 | $226,880.64 |
DisclosureSEC source: 0001209191-20-042172 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,187 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 136 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2020. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 20,688 shares of common stock and 8,499 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 20:32 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 4,305 | $92.40 | $397,789.75 |
DisclosureSEC source: 0001209191-20-039463 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,736 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $92.15 - $92.68. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 29,610 shares of common stock and 6,126 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:33 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 1,000 | $95.03 | $95,030.00 |
DisclosureSEC source: 0001209191-20-038920 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,816 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 58,865 shares of common stock and 1,419 unvested restricted stock units ("RSUs"), and 20,532 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 16:30 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,236 | $97.00 | $216,883.06 |
DisclosureSEC source: 0001209191-20-035522 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,499 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $96.71 - $97.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 23,000 shares of common stock and 8,499 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:30 UTC |
Hague William JeffersonDirector
|
SaleCommon Stock | 733 | $96.32 | $70,602.56 |
DisclosureSEC source: 0001209191-20-034690 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,476 F1 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 11,230 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 21, 2020 Filed May 22, 2020 21:11 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 300 | $93.40 | $28,019.01 |
DisclosureSEC source: 0001209191-20-031817 · doc4.xml · nonDerivative · entry 2 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,695 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $93.14 - $93.72. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 46,716 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 21, 2020 Filed May 22, 2020 21:11 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 1,977 | $92.60 | $183,061.30 |
DisclosureSEC source: 0001209191-20-031817 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,995 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $92.11 - $93.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2020 Filed May 22, 2020 21:14 UTC |
SPRIESER JUDITH ADirector
|
SaleCommon Stock | 100 | $93.72 | $9,372.00 |
DisclosureSEC source: 0001209191-20-031828 · doc4.xml · nonDerivative · entry 2 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,275 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 26,029 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 21, 2020 Filed May 22, 2020 21:14 UTC |
SPRIESER JUDITH ADirector
|
SaleCommon Stock | 935 | $92.63 | $86,609.89 |
DisclosureSEC source: 0001209191-20-031828 · doc4.xml · nonDerivative · entry 1 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,375 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $92.17 - $93.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2020 Filed May 22, 2020 17:12 UTC |
Hatfield Fred WDirector
|
SaleCommon Stock | 240 | $93.56 | $22,454.40 |
DisclosureSEC source: 0001209191-20-031821 · doc4.xml · nonDerivative · entry 2 Hatfield Fred W · CIK 0001399286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,761 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $93.21 - $93.72. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 32,515 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 21, 2020 Filed May 22, 2020 17:12 UTC |
Hatfield Fred WDirector
|
SaleCommon Stock | 1,310 | $92.58 | $121,276.53 |
DisclosureSEC source: 0001209191-20-031821 · doc4.xml · nonDerivative · entry 1 Hatfield Fred W · CIK 0001399286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,001 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $92.20 - $93.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 20, 2020 Filed May 22, 2020 17:13 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 17,693 | $0.00 Strike: $22.50 | $0.00 |
DisclosureSEC source: 0001209191-20-031826 · doc4.xml · derivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,694 Underlying: Common Stock · 17,693 shares Expires 2021-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested. Read SEC document |
| May 20, 2020 Filed May 22, 2020 17:13 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 26,675 | $93.64 | $2,497,908.35 |
DisclosureSEC source: 0001209191-20-031826 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 81,570 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F6 · price: The price range for the aggregate amount sold by the direct holder is $93.25 - $94.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F7 · balance_after: As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| May 20, 2020 Filed May 22, 2020 17:13 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 100,000 | $93.64 | $9,363,780.00 |
DisclosureSEC source: 0001209191-20-031826 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,371,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $93.09 - $94.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Read SEC document |
| May 20, 2020 Filed May 22, 2020 17:13 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 65,319 | $93.64 | $6,116,196.82 |
DisclosureSEC source: 0001209191-20-031826 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,411,142 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $93.165 - $94.09. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,330,876 shares of common stock and 80,266 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| May 20, 2020 Filed May 22, 2020 17:13 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 17,693 | $22.50 | $398,092.50 |
DisclosureSEC source: 0001209191-20-031826 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,476,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:24 UTC |
Hague William JeffersonDirector
|
Tax withholdingCommon Stock | 141 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030884 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,209 F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 11,963 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:23 UTC |
CRISP CHARLES RDirector
|
GrantCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030468 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,972 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 48,993 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:33 UTC |
NOONAN THOMAS EDirector
|
GrantCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030493 · doc4.xml · nonDerivative · entry 1 NOONAN THOMAS E · CIK 0001079742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,766 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 10,787 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:37 UTC |
TESE VINCENTDirector
|
GrantCommon Stock | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030504 · doc4.xml · nonDerivative · entry 1 TESE VINCENT · CIK 0001042445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,246 restricted stock units awarded, 1,979 were awarded as compensation for service on the Issuer's board and 267 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 34,004 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 16:34 UTC |
SALERNO FREDERIC VDirector
|
GrantCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030496 · doc4.xml · nonDerivative · entry 1 SALERNO FREDERIC V · CIK 0001180138 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,176 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 11,197 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:25 UTC |
Farooqui Duriya MDirector
|
GrantCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030472 · doc4.xml · nonDerivative · entry 1 Farooqui Duriya M · CIK 0001699994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,651 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 7,672 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:29 UTC |
Hague William JeffersonDirector
|
GrantCommon Stock | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030481 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,350 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,246 restricted stock units awarded, 1,979 were awarded as compensation for service on the Issuer's board and 267 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Futures Europe. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 12,104 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 16:27 UTC |
Forneri Jean MarcDirector
|
GrantCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030477 · doc4.xml · nonDerivative · entry 1 Forneri Jean Marc · CIK 0001343872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,811 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 19,832 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:35 UTC |
SPRIESER JUDITH ADirector
|
GrantCommon Stock | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030499 · doc4.xml · nonDerivative · entry 1 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,310 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,246 restricted stock units awarded, 1,979 were awarded as compensation for service on the Issuer's board and 267 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 27,064 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 16:30 UTC |
Hatfield Fred WDirector
|
GrantCommon Stock | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030485 · doc4.xml · nonDerivative · entry 1 Hatfield Fred W · CIK 0001399286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,311 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,246 restricted stock units awarded, 1,979 were awarded as compensation for service on the Issuer's board and 267 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 34,065 shares of common stock and 2,246 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:22 UTC |
Bowen SharonDirector
|
GrantCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030465 · doc4.xml · nonDerivative · entry 1 Bowen Sharon · CIK 0001724974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,168 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 7,189 shares of common stock and 1,979 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 15, 2021. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:28 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 3,991 | $91.26 | $364,218.66 |
DisclosureSEC source: 0001209191-20-025947 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,041 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,915 shares of common stock and 6,126 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 11,914 | $88.75 | $1,057,318.65 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 9 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 108,245 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F11 · price: The price range for the aggregate amount sold by the direct holder is $88.42 - $89.24. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F12 · balance_after: As previously reported, the reporting person also indirectly owns 108,245 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 19,700 | $87.88 | $1,731,253.73 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 8 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 120,159 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F10 · price: The price range for the aggregate amount sold by the direct holder is $87.40 - $88.39. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 35,486 | $86.49 | $3,069,052.84 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 139,859 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F9 · price: The price range for the aggregate amount sold by the direct holder is $86.12 - $86.99. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 7,900 | $85.52 | $675,590.62 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 6 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 175,345 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F8 · price: The price range for the aggregate amount sold by the direct holder is $85.11 - $86.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 1,321 | $89.12 | $117,729.50 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,471,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F6 · price: The price range for the aggregate amount sold by the direct holder is $89.06 - $89.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F7 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 27,448 | $88.60 | $2,431,999.85 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,473,026 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $88.06 - $89.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 23,854 | $87.65 | $2,090,784.02 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,500,474 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $87.06 - $88.04. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 37,024 | $86.52 | $3,203,146.17 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,524,328 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $86.06 - $87.02. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 16:27 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 10,353 | $85.59 | $886,120.52 |
DisclosureSEC source: 0001209191-20-018872 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,561,352 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $85.06 - $86.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 16:22 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,982 | $88.88 | $265,040.16 |
DisclosureSEC source: 0001209191-20-018092 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,735 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 25,236 shares of common stock and 8,499 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:19 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 17,693 | $0.00 Strike: $22.50 | $0.00 |
DisclosureSEC source: 0001209191-20-013809 · doc4.xml · derivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,387 Underlying: Common Stock · 17,693 shares Expires 2021-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.